Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases (≥95th percentile of body mass index (BMI)) and 8,318 controls (<50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P < 5 × 10 −6 in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 × 10 −9 ; odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 × 10 −9 ; OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous metaanalysis of adult BMI 1 .
Obesity is a major, increasingly prevalent health problem affecting modern societies. The problem is particularly severe for children in developed countries, where the prevalence of obesity is on the increase. Obesity present in adolescence is associated with increased overall mortality in later life 2 . Whereas the change in prevalence of obesity is likely to be explained by environmental changes over the last 30 years, there is also strong evidence for a genetic component to the risk for obesity. This is reflected in familial occurrences of childhood obesity, where the concordance of fat mass among monozygotic twins is reported to be higher than in dizygotic twins.
In the past 4 years, many genetic loci have been implicated in BMI and/or obesity phenotypes from the outcomes of genome-wide association studies (GWAS), primarily in adults. The first locus reliably found to harbor variation associated with adiposity, FTO (encoding fat mass and obesity associated) 3 , has been shown to be associated with obesity in all sufficiently sized study groups. Subsequent larger studies have identified additional loci influencing BMI and/or obesity. The largest meta-analysis of adult BMI to date came from the Genetic Investigation of ANthropometric Traits (GIANT) Consortium, which A genome-wide association meta-analysis identifies new childhood obesity loci confirmed 14 known obesity susceptibility loci and identified 18 new loci associated with BMI in a study involving a total of 249,796 individuals 1 . However, these loci only account for a small fraction of the heritability that is known to contribute to obesity. There has been some work on extreme obesity in childhood (>99.5th percentile of BMI), but little progress has been made on less marked definitions of obesity that are more relevant to public health.
We reasoned that distilling the genetic component of this complex phenotype should be easier in children, where environmental exposure and impact have occurred for a relatively short period in their lifetimes. The relationship between BMI and body fat in children varies widely with age and with pubertal maturation. The Centers for Disease Control and Prevention defined overweight as at or above the 95th percentile of BMI for age 4 . By late adolescence, these percentiles approach those used for adult definitions, with the 95th percentile corresponding to ~30 kg/m 2 (ref. 5) .
In an effort to systematically search for childhood obesity susceptibility loci, we performed a large-scale meta-analysis of 14 existing GWAS data sets for childhood obesity, totaling 5,530 cases (≥95th percentile of BMI reached before the age of 18 years, representing 5-30% of any given cohort) and 8,318 controls (relatively conservatively defined as <50th percentile of BMI consistently throughout all measures during childhood) of European ancestry (Supplementary Table 1 and Supplementary Note).
In the meta-analysis of 2.7 million SNPs (directly genotyped or imputed), signals at seven discrete locations reached genome-wide significance at P < 5.0 × 10 −8 . All these loci have previously been identified through GWAS for adult BMI (FTO, TMEM18, POMC, MC4R, FAIM2, TNNI3K and SEC16B) and robustly reflect previous reports on individual pediatric cohorts 6, 7 . FTO gave the strongest evidence for association, although TNNI3K and POMC, which were only detected in adult studies when samples came from hundreds of thousands of individuals, were also readily detected in our relatively small sample ( Fig. 1 and Supplementary Tables 2 and 3) . Excluding the French and German studies from the meta-analysis, we did not observe association with variants previously reported by these groups as novel, where the defined childhood obesity was at a higher threshold 8 , at the loci harboring TNKS-MSRA (rs17150703; P = 0.22) and SDCCAG8 (rs12145833; P = 0.57).
We took forward all eight newly identified signals yielding association with P < 5.0 × 10 −6 ( Table 1 and Supplementary Table 4 ). Heterogeneity analysis showed that the different distributions in each study did not affect the results (Supplementary Table 4) . In addition, we applied a second genomic control correction to the overall discovery meta-analysis results in order to test for replication in multiple independent existing data sets, the majority of which were in silico analyses (Supplementary Table 5 ). In our replication effort, we initially tested these eight SNPs in nine study groups that had a comparable set of affected subjects with BMI distributed normally from the 95th percentile upward (2,818 cases and 4,083 controls). In combined analysis of the discovery and replication cohorts, we observed two loci that yielded consistent evidence of association near OLFM4 (encoding olfactomedin 4) at 13q14 (rs9568856; P combined = 1.82 × 10 −9 ; OR = 1.22) and within the HOXB5 gene (encoding homeobox B5) at 17q21 (rs9299; P combined = 3.54 × 10 −9 ; OR = 1.14) ( Table 1 and Supplementary Figs. 1 and 2) .
Previous GWAS reports for extreme obesity case-control samples have both confirmed signals seen in samples with less extreme obesity or that are population based, such as FTO, as well as identified new signals that are distinct from those seen at the population level 8 . We reasoned, therefore, that further exploration in existing extreme obesity data sets (two cohorts totaling 2,214 cases (exclusively individuals who are approximately >4 s.d. above mean BMI, equating BMI > 99.5th percentile) and 2,674 controls) would offer further insight into how these signals operate, while acknowledging the phenotypic differences and limits of sample size. Indeed, both loci In the discovery stage (5,530 cases and 8,318 controls), these loci did not reach genome-wide significance but yielded P < 5 × 10 −6 . The outcome of the replication effort for these loci in nine comparable independent cohorts (totaling 2,818 cases and 4,083 controls) is shown, as is that of combined analysis, with signals at both loci reaching genomewide significance in the latter analysis.
a Plus and minus signs represent the direction of effect based on the reference allele.
l e t t e r s npg l e t t e r s emerging from the main replication stage continued to show association with the more extreme phenotype (OLFM4: rs4833407; P overall = 5.33 × 10 −9 ; OR = 1.18 and HOXB5: rs9299; P overall = 1.54 × 10 −8 ; OR = 1.13) (Supplementary Table 6 ).
As the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort leveraged BMI measures made before the age of 2 years as part of the definition of cases and controls, we performed sensitivity analyses limiting case and control definitions to children over 2 years of age (Supplementary Tables 7-9 ). In addition to no diminishment in the ORs for the OLFM4 and HOXB5 loci, we observed support for associations of rs4864201 at BC041448 (UCSC annotation) and rs4833407 at ALPK1 (Supplementary Tables 8 and 9) .
Finally, we were interested to see whether our two main signals of interest at OLFM4 and HOXB5 were evident in the GIANT Consortium adult BMI meta-analysis results (n = 123,864 study subjects). Indeed, both loci yielded evidence of association in this quantitative setting (P = 7.75 × 10 −5 and 0.015, respectively), with the same alleles being associated in the same direction in the two analyses. Overall, seven of the eight signals initially taken forward to the replication stage, with the exception of rs1290002, yielded consistent directionality, although not all were statistically significant (Supplementary Table 10) .
Taken together, these data indicate that the genetic architecture of BMI and obesity overlap to a large extent in children as well as in adults. In addition to the previously reported loci, we have uncovered at least two new loci associated with obesity in early life. The adult BMI data available from the GIANT Consortium 1 show that the influence of these two loci is also detected in adulthood. Of note, in addition to OLFM4 and HOXB5, the GIANT Consortium data support associations with three more of the eight loci initially taken forward to the replication stage, namely rs4864201 at BC041448, rs4833407 at ALPK1 and rs2300095 at MTOR-ANGPTL7, despite these signals not formally replicating in the main defined overall pediatric setting, suggesting that these loci should be studied further to fully understand their role in the pathogenesis of obesity as a whole.
OLFM4, encoding olfactomedin 4, is the nearest gene to rs9568856 but is still approximately 500 kb from the associated signal; the corresponding gene product has never been directly implicated in obesity but has been extensively studied in the context of various cancers. The OLFM4 protein is a secreted glycoprotein that facilitates cell adhesion via lectins and cadherin on the cell surface. Although the function of OLFM4 is not well understood, there are several intriguing observations that link it to gut microflora and to the relationship between the gut microbiome and obesity risk. For example, the OLFM4 gene product downregulates innate immunity to infection by the stomach bacterium Helicobacter pylori 9 , with obese subjects having a higher occurrence of H. pylori infection than their lean counterparts 10, 11 . Indeed, weight loss induced by obesity surgery eradicates H. pylori 12 .
rs9299 is in the 3′ UTR of the HOXB5 gene, encoding homeobox B5, within the HOXB gene cluster. HOXB5 is spatially and temporarily regulated during gut development 13 , and it has been suggested to have a role in obesity by a study observing upregulation of homeobox transcription factors after fat loss 14 . Therefore, it is possible that OLFM4 and HOXB5 may impact BMI via different aspects of gut function.
In summary, as a consequence of extensive North American, Australian and European collaborative genome-wide meta-analyses on children, we have uncovered two new obesity loci that have the strongest evidence for association with elevated adiposity in the first 18 years of life. Further functional characterization of these signals is required to elucidate the precise mechanisms behind these observations. 
METhOds
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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